Effects of KATP channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts

被引:21
作者
Jilkina, O
Kuzio, B
Grover, GJ
Kupriyanov, VV
机构
[1] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada
[2] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Cardiovasc & Metab Dis Drug Discovery, Princeton, NJ 08543 USA
基金
加拿大健康研究院;
关键词
oxidative phosphorylation; oxygen consumption; ATP-sensitive K+ channels; K-ATP opener; P-1075; pinacidil; diazoxide; 5-hydroxydecanoate; glibenclamide; 2,4-dinitrophenol; Rb+/K+ efflux;
D O I
10.1006/jmcc.2001.1524
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
O. JILKINA. B. KUZIO, G. J. GROVER AND V. V. KUPRIYANOV. Effects of K-ATP Channel Openers, P-1075, Pinacidil. and Diazoxide, on Energetics and Contractile Function in Isolated Rat Hearts. Journal of Molecular and Cellular Cardiology (2002) 34, 427-440. We investigated the metabolic effects of a potent opener of ATP-sensitive K+ (K,,,,) channels, P-1075. in perfused rat hearts with the help of T-31 NMR spectroscopy. A 20 min infusion of 5 mum P-1075 depleted phosphocreatine and NIT by approximately 40%, concomitantly with a two-fold increase in inorganic phosphate, while oxygen consumption by the hearts increased by 50%,. P-1075 induced a cardiac contracture (left ventricular end diastolic pressure increased from 6 to 60 mmHg) and a cardiac arrest after an infusion of approximately 9 min. The effects were fully reversed by glibenclamide (5 pm), but not by sodium 5-hydroxydecanoate (0.4 mm). A P-1075-related K-ATP opener, pinacidil (0.3 mm), partially reversed the effects of P-1075, but a structurally unrelated opener. diazoxide (0.5 mm). had no effect. Pinacidil and diazoxide alone did not significantly affect PCr and ATP levels. Bioenergetic and functional effects similar to those of P-1075 were induced by infusion of a classic mitochondrial uncoupler, 2,4-dinitrophenol (50 mum); however, they were not abolished by glibenclamide. In addition. it was shown, using (87)b NMR, that both agents, P-1075 and 14-dinitrophenol, resulted in a Stimulation of Rb+ efflux from the Rb+ loaded rat hearts by approximately 130 and 65%, respectively, in a glibenclamide-sensitive manner. An inhibitory effect of P-1075 on ATP synthesis cannot be explained by its well-known action on sarcolemmal K-ATP. channels. We concluded that, unlike all Uncoupling effect of 2,4-dinitrophenol, an inhibitory effect of P-1075 is produced by uncoupling of oxidative phosphorylation through the activation of mitochondrial K-ATP. channels. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:427 / 440
页数:14
相关论文
共 36 条
[1]   ENHANCEMENT OF POTASSIUM-SENSITIVE CURRENT IN HEART-CELLS BY PINACIDIL - EVIDENCE FOR MODULATION OF THE ATP-SENSITIVE POTASSIUM CHANNEL [J].
ARENA, JP ;
KASS, RS .
CIRCULATION RESEARCH, 1989, 65 (02) :436-445
[2]   Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes:: Correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies [J].
Atwal, KS ;
Grover, GJ ;
Lodge, NJ ;
Normandin, DE ;
Traeger, SC ;
Sleph, PG ;
Cohen, RB ;
Bryson, CC ;
Dickinson, KEJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :271-275
[3]   Polarization and myocardial protection [J].
Chambers, DJ .
CURRENT OPINION IN CARDIOLOGY, 1999, 14 (06) :495-500
[4]   THERE AN ALTERNATIVE TO POTASSIUM ARREST [J].
COHEN, NM ;
DAMIANO, RJ ;
WECHSLER, AS .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :858-863
[5]   Potassium channel openers depolarize hippocampal mitochondria [J].
Debska, G ;
May, R ;
Kicinska, A ;
Szewczyk, A ;
Elger, CE ;
Kunz, WS .
BRAIN RESEARCH, 2001, 892 (01) :42-50
[6]  
Garlid KD, 1997, CIRC RES, V81, P1072
[7]   Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning [J].
Gross, GJ ;
Fryer, RM .
CIRCULATION RESEARCH, 1999, 84 (09) :973-979
[8]  
Grover GJ, 2001, J PHARMACOL EXP THER, V297, P1184
[9]   ATP-sensitive potassium channels: A review of their cardioprotective pharmacology [J].
Grover, GJ ;
Garlid, KD .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (04) :677-695
[10]  
Hambrock A, 1999, MOL PHARMACOL, V55, P832